Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on cis 2 hydroxymethyl 4 (cytosine 1' yl) 1,3 oxathiolane. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101142211B details a robust resolution process for cis-oxathiolane cytosine derivatives, offering significant cost reduction and supply chain reliability for antiviral API manufacturing.